These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1933399)

  • 21. The potentiation of morphine-withdrawal jumping by clonidine is antagonized by m-chlorophenylpiperazine and not by haloperidol.
    van der Laan JW; Hillen FC
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):45-55. PubMed ID: 2879519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that drugs increasing 5-hydroxytryptamine transmission block jumping but not wet dog shakes in morphine-abstinent rats: a comparison with clonidine.
    Romandini S; Cervo L; Samanin R
    J Pharm Pharmacol; 1984 Jan; 36(1):68-70. PubMed ID: 6141273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol.
    Rezazadeh SM; Prather PL; Lal H
    Alcohol; 1993; 10(4):281-3. PubMed ID: 8397879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.
    Papaleo F; Contarino A
    Behav Brain Res; 2006 Jun; 170(1):110-8. PubMed ID: 16580078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats.
    Ghaemi-Jandabi M; Azizi H; Ahmadi-Soleimani SM; Semnanian S
    Brain Res Bull; 2017 Apr; 130():107-111. PubMed ID: 28093335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine.
    Rada P; Pothos E; Mark GP; Hoebel BG
    Brain Res; 1991 Oct; 561(2):354-6. PubMed ID: 1802350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of trazodone metabolism in its inhibitory action on avoidance response.
    Sansone M; Melzacka M; Vetulani J
    Pharmacol Biochem Behav; 1985 Jul; 23(1):137-40. PubMed ID: 4034616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats: relation to blockade of naloxone precipitated jumping by serotonin agonists.
    Samanin R; Cervo L; Rochat C; Poggesi E; Mennini T
    Life Sci; 1980 Sep; 27(13):1141-6. PubMed ID: 7191464
    [No Abstract]   [Full Text] [Related]  

  • 30. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
    Kang L; Wang D; Li B; Hu M; Zhang P; Li J
    Am J Drug Alcohol Abuse; 2008; 34(5):541-52. PubMed ID: 18618337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms.
    Shahidi S; Hasanein P
    Brain Res Bull; 2011 Aug; 86(1-2):118-22. PubMed ID: 21763761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA; Murphy DL; Sunderland T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary study of the biotransformation of two new drugs, trazodone and etoperidone.
    Melzacka M; Rurak A; Vetulani J
    Pol J Pharmacol Pharm; 1980; 32(4):551-6. PubMed ID: 7255270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates.
    Szele FG; Murphy DL; Garrick NA
    Life Sci; 1988; 43(16):1297-303. PubMed ID: 3172981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cholinergic drugs on acute and chronic morphine dependence.
    Padmanabha Pillai N; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):146-54. PubMed ID: 7202346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of a 5-HT7 receptor agonist and antagonist on morphine withdrawal syndrome in mice.
    Shahidi S; Hashemi-Firouzi N
    Neurosci Lett; 2014 Aug; 578():27-32. PubMed ID: 24954075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal.
    Stinus L; Le Moal M; Koob GF
    Neuroscience; 1990; 37(3):767-73. PubMed ID: 2247222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.